The shigellosis gastroenteritis treatment market — addressing bacterial dysentery caused by Shigella species and treated through a combination of antibiotic therapy and rehydration strategies — is expanding steadily as antimicrobial resistance transforms what was once a straightforward, low-cost infection into a genuinely more complex and expensive clinical challenge, with the...